Lundbeck
Annette Heydenreich is a seasoned professional in drug development and formulation sciences with extensive experience across various leading companies in the pharmaceutical industry. Currently serving as a Senior Drug Product Specialist at Lundbeck since December 2024, Annette's previous roles include Associate Scientific Director and Principal Scientist at Symphogen, where responsibilities focused on formulation and drug product development. At Novo Nordisk, Annette specialized in formulation development for peptides, proteins, and mAbs. Annette's earlier experience includes senior analytical roles at Veloxis Pharmaceuticals, where analytical methods for solid oral dosage forms were developed, and leadership in CMC and Quality at Nordic Vaccine. Annette's academic background features a Master's degree in Pharmaceutics from Danmarks Farmaceutiske Universitet and a PhD focused on mucosal DNA vaccine delivery.
This person is not in the org chart
This person is not in any teams
Lundbeck
42 followers
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.